Three-drug combo improves lung function in most common genetic form of cystic fibrosis
A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic mutation for the disease.
Read Original Article: Three-drug combo improves lung function in most common genetic form of cystic fibrosis »
